1. Introduction {#sec0005}
===============

1.1. Coronavirus enteritis in pigs {#sec0010}
----------------------------------

Coronavirus enteritis is a highly contagious viral disease in pigs characterized by severe diarrhea, vomiting, and dehydration with a high mortality, especially in neonatal piglets less than 2 weeks of age. Transmissible gastroenteritis virus (TGEV) is a frequent cause for endemic and epidemic viral enteritis in neonates and older pigs ([@bib0360], [@bib0410]), and porcine epidemic diarrhea virus (PEDV) has become a major concern in the swine industry in the US since its emergence in April 2013. As with TGEV, PEDV causes severe enteritis in newborn piglets but the mortality can be much higher and may reach up to 100% during epidemics ([@bib0145], [@bib0685]). PED was first described in the UK in the early 1970s and has since become endemic in some parts of Europe. Highly virulent PEDV has emerged in Asia and subsequently in the US ([@bib0110], [@bib0115], [@bib0480], [@bib0500], [@bib0695]). PEDV has since quickly spread to most states and as of April 2016, 36 states have become endemic for PEDV, raising a significant economic concern ([www.aphis.usda.gov/animal-health/secd](http://www.aphis.usda.gov/animal-health/secd){#intr0005}). PDCoV is a newly emerged swine enteric coronavirus causing enteritis and severe diarrhea in piglets, which was first described in a surveillance study 2012 in Hong Kong, China ([@bib0790]). PDCoV is an additional enteric virus emerged in the US in February 2014 ([@bib0760]). PDCoV has been identified in the feces and intestinal samples of pigs experiencing severe diarrhea without PEDV and TGEV ([@bib0760]). Retrospective studies show that PDCoV has been present in the US at least since August 2013 ([@bib0490], [@bib0665]). PDCoV has also spread to at least 20 states of the US ([www.aphis.usda.gov/animal-health/secd](http://www.aphis.usda.gov/animal-health/secd){#intr0010}), Korea, and China ([@bib0170], [@bib0420]). PDCoV infection seems clinically milder with a lower death rate of 30--40% in neonates than typical PEDV infection ([@bib0760]), but co-infection with PEDV, TGEV, or porcine rotavirus is common and result in a severe form of disease ([@bib0485], [@bib0760]). Clinical symptoms by PDCoV are reproducible in both gnotobiotic pigs and conventional pigs and present diarrhea accompanied by severe histopathological lesions such as villi atrophy in the absence of other pathogens ([@bib0120], [@bib0315], [@bib0470]). Although the clinical signs and pathological lesions are indistinguishable among PEDV, TGEV, and PDCoV ([@bib0300]), these coronaviruses are antigenically distinct and thus the cross-protection is absent ([@bib0455]). Pathogenesis of these coronaviruses may include destruction of enterocytes and villous atrophy of the intestinal mucosa in the jejunum and ileum ([@bib0145], [@bib0300]).

Coronaviruses are enveloped viruses containing the genome of single-stranded positive-sense RNA in the family *Coronaviridae*. The coronavirus genome ranges of 28--30 Kb in length and is currently the largest known viral RNA genome. Coronaviruses are grouped in the *Coronavirinae* subfamily which is comprised of 4 genera; *Alpha*-, *Beta*-, *Gamma*- and *Delta*-coronaviruses (<http://www.ictvonline.org/virustaxonoym.asp> \[ICTV, 2014\]). Evolutionary studies suggest that *Alphacoronavirus* and *Betacoronavirus* are originated from bats while *Gammacoronavirus* and *Deltacoronavirus* are from birds ([@bib0790]). In humans, coronaviruses infect the respiratory tract and cause symptoms ranging from common colds to severe pneumonia and acute respiratory distress. Severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) belong to *Betacoronavirus*, and cause lower respiratory tract infections of significant public concerns ([@bib0225]). Among swine enteric coronaviruses, TGEV and PEDV belong to *Alphacoronavirus* and share a similar genome organization, whereas PDCoV belongs to *Deltacoronavirus* (<http://www.ictvonline.org/virustaxonomy.asp>).

The PEDV genome is approximately 28 Kb in length with the 5′-cap and 3′-polyadenylated tail. The genome is arranged with ORF1a-ORF1b-S-ORF3-E-M-N in order with both termini flanked with untranslated regions (UTRs) ([@bib0175]). ORF1a codes for a large polyprotein pp1a, while ORF1b is expressed as the pp1ab fusion protein via the ribosomal frameshifting. These polyproteins are proteolytically cleaved to 16 nonstructural proteins, nsp1 through nsp16, by the proteinase activity of nsp3 and nsp5. The TGEV genome is similar to that of PEDV and arranged as ORF1a-ORF1b-S-ORF3a-ORF3b-E-M-N-ORF7 in order ([@bib0010]). For PEDV, ORF3 encodes the sole accessory protein, whereas for TGEV, three accessory proteins are encoded by ORF3a, ORF3b, and ORF7 ([@bib0070]). The PDCoV genome is the smallest of the three coronaviruses with 26 Kb in length, and includes two accessory genes of NS6 and NS7 with the gene order of ORF1a-ORF1b-S-E-M-NS6-N-NS7 ([@bib0790]). Notably, PDCoV lacks of the nsp1 gene and thus codes for only 15 nsps in total. Genomic similarities and dissimilarities for α-, β-, γ-, and δ-coronaviruses are illustrated in [Fig. 1](#fig0005){ref-type="fig"} .Fig. 1Comparative genome organization of the representative coronaviruses from each genus in the family Coronaviridae. Swine enteric coronaviruses (TGEV, PEDV, and PDCoV) are indicated in bold underlined. Structural proteins are presented in green. Putative accessory proteins are shown in blue. Nonstructural proteins in ORF1a/b are presented in grey or other colors. Papain-like proteinases (PLP1 and PLP2), coronavirus 3C-like proteinase (3Cpro), RNA-dependent RNA polymerase (RdRp), two viral nucleases (nsp14 as exonuclease and nsp15 as endonuclease), and 2′-*O-*methytransferase (2MT; nsp16) are indicated by respective nsp numbers. The genome for *Alaphacoronavirus* and *Betacoronavirus* contains the nsp1 gene in different lengths, whereas the genome for *Gammacoronavirus* and *Deltacoronavirus* lacks the nsp1 gene. TGEV, transmissible gastroenteritis coronavirus; PEDV, porcine epidemic diarrhea virus; NL63, human coronavirus NL63; BCoV, bovine coronavirus; SARS-CoV, severe acute respiratory syndrome coronavirus; MERS-CoV, middle east respiratory syndrome coronavirus; IBV, avian infectious bronchitis virus; PDCoV, porcine deltacoronavirus; HE, hemagglutinin-esterase; S, spike; E, envelope; M, membrane; N, nucleocapsid; I, internal open reading frame.Fig. 1

1.2. Early response to viral infection {#sec0015}
--------------------------------------

Upon virus infection, a host reacts quickly to invading virus by producing type I interferons (IFN-α/β) and elicits an antiviral state in infected cells and uninfected neighbor cells. Three different types of IFNs are known: type I (IFN-α/β), type II (IFN-γ), and type III (IFN-λ) IFNs ([Table 1](#tbl0005){ref-type="table"} ). For humans, type I IFNs contain 13 subtypes of IFN-α and a single subtype for IFN-β, IFN-ε, IFN-κ, and IFN-ω. For pigs, IFN-α is produced from as many as 17 functional genes. For type II IFN, only a single subtype of IFN-γ is reported for pigs, which is produced largely in immune cells. Type III IFNs include IFN-λ1 (interleukin 29 \[IL-29\]), λ2 (IL-28A), λ3 (IL-28B), and IFN-λ4 ([@bib0380], [@bib0585], [@bib0645]).Table 1Types of interferons, antiviral functions, and their cellular receptors.Table 1IFN typeSubtypeChomosomal locusCelluar sourceAntiviral functionIFN receptorReceptor distributionType I IFNIFN-α (17 for pig, and 13 for human),\
IFN-β (1),\
IFN-ε (1),\
IFN-κ (1),\
IFN-ω (1)1 for pig,\
9 for human, 4 for mouseNearly all nucleated cells produce IFN-β.\
IFN-α subtypes are primarily produced by leukocytes.\
pDCs are the most potent type I IFN producers.\
IFN-κ and IFN-ε produced in a tissue-specific manner.Potent antiviral activities.IFNAR1 and IFNAR2Nearly all nucleated cells, except intestinal epithelial cells (IECs).Type II IFNIFN-γ (1)5 for pig,\
12 for human,\
10 for mouseMade primarily by immune cells such as CD4 and CD8 T cells, NK and NKT cells, DCs, and macrophages.More of an interleukin than an interferon.\
Modest antiviral activity.IFNGR1 and IFNGR2Broad tissue distribution.Type III IFNIFN-λ (4)14 for pig,\
19 for human,\
7 for mouseA variety of human primary cell types of hematopoietic lineage.\
Epithelial cells are the potent producers for type III IFNs among the nonhematopoietic cells.Largelyrestricted to epithelium.\
lung epithelium responds to both type I and III IFNs.\
IECs respond exclusively to type III IFNs.IFNLR1 and\
IL-10R2IL-10R2 is widely distributed across cell types.\
IFNLR1 is mainly restricted to epithelial cells.

Different types of IFNs signal through different receptors. IFN-α/β signal through a heterodimeric complex composed of a single chain of IFN-α receptors 1 (IFNAR1) and 2 (IFNAR2), which are believed to be expressed on the cell surface of all nucleated cells ([@bib0220], [@bib0570]). IFN-γ forms a homodimer for signaling through the IFN-γ receptor (IFNGR) complex, which is composed of dimer of two transmembrane-spanning receptors \[IFN-γ receptors 1 (IFNGR1) and 2 (IFNGR2)\] with broad tissue distributions. IFN-λ signals through heterodimers of interleukin-10 receptor 2 (IL10R2) and IFN-λ receptor 1 (IFNLR1). While IL-10R2 is widely distributed in different cell types, IFNLR1 is largely restricted to epithelial cells ([@bib0680]), and thus subtypes of IFN-λ limit their antiviral functions to epithelial cells. All IFNs activate the Janus kinase (JAK)-signal transducer and activator of transcription (STAT) signaling pathway to establish an antiviral state. Since IFNGR1/2 are widely distributed, most cell types are capable of responding to IFN-γ ([@bib0740]). While the IFN-γ has pleiotropic effects on immune cells, a direct antiviral activity is rather limited. In contrast, both IFN-α/β and IFN-λ induce a potent antiviral state by regulating the expression of hundreds of interferon stimulating genes (ISGs). Even though IFN-α/β and IFN-λ utilize different receptors for downstream signaling, their induction and antiviral mechanism are similar, and *in vivo* studies for IFN-λ show a high degree of redundancy of these two IFN systems in lung epithelial cells ([@bib0030], [@bib0505], [@bib0510]), raising a question that why two seemingly redundant antiviral systems exist. IFN signaling cascades are summarized in [Fig. 3](#fig0015){ref-type="fig"}.

Swine enteric viruses are mostly transmitted via the fecal-oral route and a possible aerosol transmission and some of them are highly infectious. TGEV infects and replicates primarily in small intestinal enterocytes and to a lesser extent in the respiratory tract ([@bib0360]). PEDV and PDCoV also infect the small intestinal enterocytes ([@bib0315], [@bib0295]), and thus intestinal epithelial surface is the first line of host defense to prevent enteric viral infections. Due to the distinctive features of the intestinal epithelial mucosal surface, induction and signaling of IFNs are unique. Coronaviruses have a large genome and have evolved to carry redundant mechanisms to counteract the host innate immune response. For SARS-CoV, at least 11 viral proteins have been identified as type I IFN antagonists ([@bib0370], [@bib0650], [@bib0735]), and a recent study for PEDV shows that at least 10 viral proteins are type I IFN antagonists ([@bib0835]). By contrast, acute infection of TGEV induces a high level of IFN-α in newborn pigs ([@bib0390]). Despite the variation of genome organization, swine enteric coronaviruses seem to utilize similar but distinct mechanisms for activation and evasion of host innate immunity on the intestinal epithelial surface.

A wealth of information is available for IFNs about their mechanisms of induction, signaling cascades, and functions, but many fundamental questions still remain to be answered, especially for their roles for intestinal antiviral innate immunity. The current review discusses the activation and modulation of innate immune responses mediated by swine enteric coronaviruses. More specifically, the mechanisms of viral proteins that modulate host innate antiviral defense and the roles of different types of IFNs in the intestinal innate immunity are described.

2. Production of type I IFNs and the IFN signaling {#sec0020}
==================================================

The host innate immune system utilizes PRRs (pattern-recognition receptors) to sense and respond to PAMPs (pathogen-associated molecular patterns) of invading viruses ([@bib0345]). This recognition of the membrane-bound PRRs triggers the activation of IFN induction pathway. Toll-like receptors (TLRs) are among the best-characterized groups of PRRs ([@bib0345]). TLRs constitutes a family of single transmembrane proteins with ectodomains containing the leucine-rich repeats for recognition of PAMPs and a cytosolic TIR (toll/IL-1 receptor) domain as a key domain transducing signals to downstream adaptors including TRIF (TIR-containing adaptor protein inducing IFN-β) and MyD88 (myeloid differentiation primary response gene 88) ([@bib0340]). Among TLRs, TLRs 3, 7, 8, 9, and 13 are involved in endosomal nucleic acid sensing. TLR3 is the dsRNA sensor and responds to poly(I:C), a synthetic RNA analog ([@bib0330], [@bib0540]). TLR7 and TLR8 recognize ssRNA derived from RNA viruses ([@bib0155], [@bib0235]), whereas TLR9 senses CpG DNA motifs in the genome of DNA viruses ([@bib0745]). TLR13 has recently been identified as the sensor for bacterial 23 S ribosomal RNA ([@bib0545]). The RLR (RIG-I-like receptor) family is responsible for the sensing of cytosolic RNA. The RLR members include RIG-I (activated retinoic acid-inducible gene I), MDA5 (melanoma differentiation gene 5), and LPG2 (laboratory of genetics and physiology 2). RIG-I and MDA5 respond to poly(I:C), with their specificities based on the length of dsRNA. RIG-I senses shorter dsRNA (∼300 bp) containing a 5′-triphosphate panhandle structure, whereas MDA5 recognizes long dsRNA ( \> 4 kb) fragments ([@bib0335], [@bib0620], [@bib0625]). Cytoplasmic DNA sensors have been addressed including STING (stimulator of IFN genes) and cGAS (cyclic GMP-AMP synthase) for cytosolic DNA sensing ([@bib0275], [@bib0705], [@bib0795]). For type I IFNs production, activated RIG-I or MDA5 binds to the mitochondrial adaptor protein MAVS/IPS-1 and recruits TRAF3 (TNF receptor-associated factor 3) and TRAF6. TRAF3 activates downstream IKK (IκB kinase) related kinases such as TBK1 (TANK-binding kinase 1) and IKKε for induction of IRF3/IRF7-dependent type I IFN production ([@bib0195], [@bib0640]). TRAF6 leads to TAK1 activation, followed by NF-κB activation for type I IFN and other cytokine productions ([@bib0590]). Within the IFN-β promoter, there are four regulatory cis elements, namely, the positive regulatory domains (PRDs) I, II, III, and IV. PRD I/III, PRD II, and PRD IV are binding sites for IRFs, NF-κB, and ATF-2/c-Jun (AP-1), respectively ([@bib0255]). The expression of IFN-β requires the assembly of these regulatory factors on PRDs to form an enhanceosome complex, which recruits CBP for IFN production ([@bib0595]). Following production and secretion, IFNs bind to the cell surface receptors to trigger the activation of JAK-STAT pathway for the IFN-signaling cascade. The three different IFN systems signal through distinct IFN receptors. Type I IFNs and type III IFNs trigger the formation of ISGF3 complex for the production of hundreds of ISGs. In contrast, type II IFN triggers the phosphorylation of STAT1 and subsequent formation of IFN-γ activation factor (GAF) for antiviral genes expression ([@bib0630]).

Expression of the membrane-bound PRRs is cell type-dependent. Specific molecular features of the PRRs and the cell type that recognizes them are two main factors for the specificity in IFN subtype production ([@bib0245]). Nearly all nucleated cells are capable of producing IFN-β through activation of IRF3 and NF-κB, but IFN-α subtypes are primarily produced by leukocytes ([@bib0080]). Plasmacytoid dendritic cells (pDCs) are the most potent type I IFN producers with up to a hundred to a thousand times more IFN-α than other cell types ([@bib0660]). Activated pDCs migrate to the lymph nodes and potentially influence various cell types through the secreted IFNs. How IFN responses vary during virus infection is still unclear. A recent study shows that different IFN responses depend on the activation of pDCs by interactions with infected cells or virus alone ([@bib0200]). Levels of total IFN-α production in pDCs vary greatly with invading virus, time, and amount of inoculum ([@bib0725]). Another study shows that pDCs produce a highly uniformed IFN-α profile regardless of the PAMP ([@bib0720]). The ratios between different IFN subtypes may be optimized by evolution in a specific cell type. Similar to IFN-α/β, IFN-λ can be induced in different cell types by various viruses. IFN-λ can be expressed in a variety of cell types of the hematopoietic lineage, which also produces IFN-α/β in abundance. Among the nonhematopoietic cells, epithelial cells are potent producers for IFN-λ. The IFN-λ response is largely restricted to the epithelium such that lung epithelial cells respond to IFN-α/β and IFN-λ and intestinal epithelial cells respond exclusively to IFN-λ ([@bib0510], [@bib0580], [@bib0680]).

3. Role of IFNs on the intestinal epithelial surface {#sec0025}
====================================================

3.1. Intestinal epithelial barrier {#sec0030}
----------------------------------

Small intestinal epithelial cells (IECs) form a physical barrier to segregate the mucosal immune system and commensal microbial communities in the lumen. The Paneth and goblet cells secrete mucus and antimicrobial proteins to exclude invading bacteria and viruses from the epithelial surface, and renewal of the epithelial cell layer is controlled by the intestinal stem cells in the crypts. Secreted IgA (sIgA) also contributes to the barrier function. The lamina propria is made of stromal cells, B cells, T cells, dendritic cells, and macrophages. Intraepithelial lymphocytes (IELs) are localized between IECs, and these cells constitute a large and highly conserved T cell compartment, which serves through cytolysis of dysregulated IECs and renewal of IECs. Microfold (M) cells are found in the gut-associated lymphoid tissues (GALT) of the Peyer's patches and the mucosa-associated lymphoid tissue (MALT) of other parts of the gastrointestinal tract, and they are specialized for antigen sampling and initiation for mucosal immune responses ([@bib0575]). Unlike the lung epithelium, the intestinal epithelium has to maintain the tolerance to the symbiotic gastrointestinal microflora while mounting an effective immune response during infection. The intestinal epithelial barrier is depicted in [Fig. 2](#fig0010){ref-type="fig"} .Fig. 2Infection of porcine enteric coronaviruses and innate immune defense at the intestinal epithelial barrier. PEDV suppresses IFN-α/β production and PEDV-specific viral antagonists have been identified (see text). Some questions need to be explored for host-PEDV/PDCoV interactions and their pathogenic mechanisms. Question marks (red) indicate unknown mechanisms that remain to be studied as described in the text. IEC, intestinal epithelial cells; IEL, intraepithelial lymphocytes; DC, dendritic cells.Fig. 2Fig. 3Modulation of type I IFN response by PEDV proteins. After binding to the celluar receptor APN, PEDV is internalized into target cells by direct fusion of viral-cellular membranes, and the viral genomic RNA is released into the cytosol for replication. The single-stranded viral RNA as well as dsRNA as a replicative intermediate are sensed by host innate nucleic acids sensors in the cytoplasm and the endosome. The activation of innate immune sensors further initiates the production of type I interferons or pro-inflammatory cytokines after binding of activated NF-κB, AP-1, IRF3, and IRF7 to the respective PRD regions. Type I IFNs are secreted and bind to the cell surface receptors of both virus-infected and non-infected neighbor cells to induce the nuclear localization of ISGF3 complex. Activation of JAK-STAT pathway induces the production of hundreds of interferon stimulating genes (ISGs) for establishment of the antiviral state. The PEDV IFN antagonists intervene the IFN signaling pathway at different stages. The modulation of the type I IFN response by PEDV and PEDV proteins are shown in yellow boxes.Fig. 3

3.2. Roles of IFN-α/β and IFN-λ in the intestine {#sec0035}
------------------------------------------------

Type I IFNs (IFN-α/β) are major cytokines to restrict viral infections. Recent studies however shed a new light on the importance of IFN-λ for restricting viral infection in the intestinal epithelium. In the rotavirus model, IFN-α/β rather play a minor role for restricting viral infections, and instead IFN-λ play a major role to inhibit viral replication in the intestinal epithelium ([@bib0020], [@bib0580]). IECs strongly respond to IFN-λ but only marginally respond to IFN-α/β *in vivo*. The effects of IFN-α/β and IFN-λ are compartmentalized with the major effect of IFN-α/β on the intestinal lymphocytes and IFN-λ on the epithelial cells ([@bib0580]). Distinct roles of IFN-α/β and IFN-λ for controlling systemic and local dissemination of rotavirus, respectively, have been suggested. IFN-α/β produced by mucosal pDCs can enhance B cell response to promote viral clearance and protection against re-infection ([@bib0140]). For rotavirus, significance of IFN-α/β seems to vary depending on the viral strains, host, and synergy with other types of IFNs, but IFN-λ determines localized intestinal epithelial antiviral defense. A recent finding shows that activated IELs upregulate the IFN-α/β and IFN-λ expression to mount a rapid antiviral state for protection of IECs ([@bib0715]). Activation of IELs *in vivo* rapidly provokes ISGs expression through the IFN-α and IFN-λ receptors. Thus, activation of IELs offers an overt means to promote an innate antiviral potential of the intestinal epithelium.

Resistance of invading viruses in the gut epithelium relies mainly on IFN-λ, not IFN-α/β, which raises a question on the ubiquitous expression of receptors for IFN-α/β. A recent study shows that mouse IECs minimally express functional type I IFN receptors and thus do not respond to type I IFNs, explaining why the IFN-α/β system is unable to compensate the IFN-λ deficiency during enteric epitheliotropic viral infections ([@bib0475]). This study shows that virus-infected IECs are potent producers of IFN-λ, suggesting that the gut mucosa possesses a compartmentalized IFN system in which epithelial cells respond predominantly to IFN-λ, whereas other cells of the gut rely on IFN-α/β for antiviral defense. Timely production of IFN-λ in IECs drives rapid clearance of intestinal viral infections and limits viral shedding in the feces. The intestinal epithelium responds exclusively to IFN-λ in a non-redundant fashion to control epitheliotropic viruses ([@bib0580]). For reovirus, IFN-λ restricts initial viral replication and reduces viral shedding in the feces, whereas IFN-α/β are critical for the prevention of systemic infection. Similarly, norovirus infection also requires IFN-λ to control persistent enteric infection, although IFN-α/β restrict the systemic spread ([@bib0525]).

In the gut, the protective effect of the innate immunity, in particular IFN-λ, is counteracted by intestinal commensal bacteria ([@bib0040]). PEDV infection causes the decrease of commensal bacteria normally present in the healthy gastrointestinal tract and induces an unbalanced shift of gut microbiota ([@bib0375], [@bib0465]), suggesting a possible modulation of IFN-λ response by PEDV. The border surface of the intestinal epithelium is the major entry site for enteric viruses and specific mechanisms are needed for the fail-safe protection of such multi-layered surfaces. Although IFN-λ production by IECs is required, it is not sufficient for protection of the epithelium from rotavirus-induced cell damages. The production and release of IL-1α by IECs following rotavirus infection enhances IL-22 production. A recent study identifies a cooperation of IFN-λ and IL-22 to synergistically curtail mucosal viral infection ([@bib0240]). The receptors for IL-22 and IFN-λ are restricted to epithelial cells and simultaneous engagement of both receptors on IECs is required for restriction of rotavirus infection, suggesting a second layer control is necessary ([@bib0240]). Downregulation of IFNLR1 and interference of the STAT1 signaling may be an important strategy for viral evasion ([@bib0635]).

After stimulation with poly(I:C) and infection with reovirus, both IECs and hematopoietic cells in the intestinal epithelium express IFN-λ strongly and quickly but do not express IFN-α/β genes ([@bib0475]). Thus, mechanisms seem to have evolved to produce IFN-λ specifically and potently in the intestinal epithelium. Since common pathways are believed to be utilized for induction of both IFN-α/β and IFN-λ ([@bib0550]), the IFN-α/β pathway is specifically blocked in IECs by an unknown mechanism. Another study shows that peroxisome-bound MAVS may preferentially activate IFN-λ expression ([@bib0530]). Nlrp6 (nucleotide-binding oligomerization domain-like receptor 6) is an intracellular protein specific for tissues and cell-types with the highest expression in IECs ([@bib0180]). Nlrp6 binds to viral RNA via the RNA helicase Dhx15 as a RNA sensor and triggers MAVS-dependent expression of IFN-α/β and IFN-λ plus ISGs, and thus plays an important role for intestinal antiviral response ([@bib0770]).

Using gene-knockout mice for specific IFN receptors, IFN-λ has been identified to play an important role in the defense against SARS-CoV and other respiratory viral infections ([@bib0510]). Fecal shedding of SARS-CoV can be detected from mice lacking both receptors for IFN-α/β and IFN-λ but not from mice lacking single receptors, suggesting that IFN-λ controls viral infections in epithelial cells of both respiratory and gastrointestinal tracts. Relative contributions of the various IFN subtypes for restricting enteric coronavirus infections remain elusive. Both TGEV and PEDV can infect and replicate in PAMs in the respiratory tract *in vivo* ([@bib0555]). PEDV has also been shown to infect macrophages infiltrated in the lamina propria and modulates immune responses after infection of monocyte-derived DCs (MoDCs) and intestinal DCs ([@bib0215], [@bib0430]). In summary, IFN-λ seems to be critical to efficiently restrict enteric coronavirus infections in the intestinal epithelial surface, including PEDV, TGEV, and possibly PDCoV infections, and in turn, these viruses may modulate the host IFN-λ response. It is of great interest to investigate how such enteric coronaviruses regulate the IFN-λ response in pigs. A full-length infectious cDNA clone is available for PEDV, and it will be useful to study individual gene functions using replicating mutants *in vivo*. As such, we will be able to better understand the pathogenic mechanisms of porcine enteric coronaviruses and host responses to such infections ([@bib0050], [@bib0280]).

4. Modulation of IFN response by porcine enteric coronaviruses {#sec0040}
==============================================================

4.1. Aminopeptidase N (CD13) as the cellular receptor and viral tissue tropism {#sec0045}
------------------------------------------------------------------------------

For coronaviruses, S protein and its interaction with a receptor on susceptible cells determine the host range and viral tropism ([@bib0060], [@bib0210]). Unlike many other coronaviruses, cell culture adaptation of PEDV triggers mutations in the S protein sequence ([@bib0415]) and requires the supplement of an exogenous protease, typically trypsin, to activate the S protein to induce membrane fusion after binding to the cellular receptor ([@bib0250], [@bib0565], [@bib0780]). The trypsin dependency of PEDV *in vitro* is consistent with the tissue tropism of trypsin-rich small intestine in pigs. Some of cell-adapted PEDV strains lose the trypsin-dependency ([@bib0515], [@bib0780]). PEDV-infected cells produce distinct cytopathic effects including cell fusion, multinucleated syncytia formation, vacuolation, and detachment due to apoptotic cell death ([@bib0350]). A recent study shows that heparan sulfate on the cell-surface may function as an attachment factor for PEDV ([@bib0260]). As with TGEV, PEDV also utilizes aminopeptidase N (APN; CD13) as a functional receptor. APN is a heavily glycosylated transmembrane protein and is expressed by most cells of myeloid origin including monocytes, macrophages, granulocytes, and their hematopoietic precursors ([@bib0105], [@bib0495], [@bib0600]). It is also abundantly expressed in the brush border of epithelial cells from the small intestine and renal proximal tubules and some other cell membranes. In the small intestine, it plays a role in the final digestion of peptides generated from hydrolysis of proteins by gastric and pancreatic proteases ([@bib0385]). TGEV utilizes APN as receptor for entry into swine testis (ST) cells, which however cannot render efficient propagation of PEDV ([@bib0150]). This differentiation may due to the relatively low level expression of APN on ST cells ([@bib0440]). Over-expression of APN enhances PEDV infection, and an increased APN density enhances the PEDV susceptibility in cultured ST cells ([@bib0440], [@bib0515], [@bib0535]). Porcine intestinal tissues are more sensitive for high-titer virus production for PEDV natural infection, which may due to the abundant expression of APN in porcine intestinal brush border membrane ([@bib0440]). Collectively, the high level expression of APN at the intestinal barrier correlates with the efficient replication of both TGEV and PEDV, and infectivity of PEDV is more dependent on APN density. Additionally, PEDV also infects cultured cells of pigs, humans, monkeys, and bats, which suggests that PEDV may utilize APN of other species origin or other unidentified receptors or co-receptors for efficient entry ([@bib0460], [@bib0835]). Both PEDV and TGEV infect alveolar macrophages besides small intestinal epithelial cells ([@bib0400], [@bib0555]). PEDV also infect infiltrated macrophages in the lamina propria *in vivo* ([@bib0430]). Even though the clinical signs of epidemic PEDV and TGEV infections are indistinguishable, it is of great interest to investigate whether the cell and tissue tropism contributes to the differential pathogenesis *in vivo*.

4.2. Activation of IFN-α/β by TGEV {#sec0050}
----------------------------------

Porcine enteric coronaviruses replicate in IECs and are transmitted via a fecal-oral route. The viral entry and release for TGEV are restricted to the apical surface of polarized epithelial cells ([@bib0615]). Experimental infection of newborn piglets with TGEV induces a strong and early IFN-α production in serum and intestinal secretions ([@bib0390]). The blocking of the viral receptor still induces IFN-α response, indicating that the entry is not needed for IFN induction in leukocytes ([@bib0605]). Early and strong IFN-α production can also be induced in nonimmune cells after exposure to TGEV-infected epithelial cells ([@bib0095]). The rapid and massive release of IFN-α in serum is mediated by M and E proteins of TGEV ([@bib0095], [@bib0405], [@bib0605]). A specific point mutation in the M protein results in lower IFN-α induction as compared to wild-type virus ([@bib0690]), and the virus-like particles made of M and E proteins induce IFN-α production in porcine leukocytes as almost efficiently as fully infectious TGEV ([@bib0045]). However, reconstituted virosomes lose the ability to induce IFN-α production, indicating that the native envelope structure is essential ([@bib0605]). Immunohistochemistry analysis of the tissues from TGEV-infected piglets show that IFN-α-producing cells (IPCs) are almost exclusively detected in the intestinal tissues and mesenteric lymph nodes (MLNs) at an early time of infection such as 6 h and disappeared by 24 h ([@bib0610]). The majority of IPCs are localized between enterocytes in the epithelial layer, the lamina propria, around the Peyer's patches, and are accumulated in the MLNs ([@bib0610]). The number of IPCs in spleen or peripheral lymph nodes is limited, and thus circulating IFN-α is likely originated from the gut and MLNs triggered by virus ([@bib0610]). IPCs in pigs are identified as pDCs ([@bib0700]). Interestingly, gut-associated IPCs express swine leucocyte antigen II (SLA II) and are distinct from TGEV-positive cells, suggesting that these cells may be the mucosal counterparts of the intestinal pDCs ([@bib0610]). Contrary to pDCs that produce high levels of IFN-α and TNF-α after infection, porcine monocyte-derived DCs do not respond to TGEV ([@bib0230]). The frequency of intestinal pDCs however is low comparing to other DCs, and thus the limited populations of intestinal pDCs may not be a major subset of antigen-presenting DCs. The production of IFN-α by intestinal pDCs in MLNs may flood the T cell area to influence the immune outcome ([@bib0100]). In addition to the production of IFN-α/β, TGEV induces phosphorylation and nuclear translocation of STAT1 in virus-infected cells and enhances the expression of ISGs ([@bib0015]). TGEV infection also promotes the p53 signaling to regulate apoptosis, and the viral nucleocapsid protein is responsible for this action and the cell cycle arrest ([@bib0160], [@bib0270]).

IFN-α has been shown to inhibit TGEV protein expression without reducing viral RNA in TGEV-infected cells ([@bib0290]). Infection of TGEV upregulates the expression of 2′-5′-oligoadenylate (2′-5′A) synthetase for inhibition of viral replication ([@bib0065], [@bib0290]). Swine IFN-α has been shown to enhance the protection from TGEV and alleviate clinical signs in piglets when orally co-administered with *Salmonella enterica* serovar Typhimurium expressing swine IFN-α with or without cytokine IL-18 ([@bib0365], [@bib0435]). The viral load is significantly reduced in intestinal segments of piglets when treated with an IFN inducer before challenge, but no reduction in viral yields is seen when simultaneously inoculated with TGEV and IFN-α, suggesting that IFN may be more useful prophylactically ([@bib0285]).

4.3. PEDV pathogenesis and innate signaling {#sec0055}
-------------------------------------------

PEDV is cytolytic with an acute necrosis in IECs, leading to villous atrophy in the small intestine ([@bib0300]). The high mortality of PEDV in piglets is associated with extensive dehydration resulting from severe villous atrophy. The severe dehydration may due to the extensive structural destruction and disorganization of tight junctions and adherens junctions during infection in nursing piglets ([@bib0310]). The slower turnover of the enterocytes, which is mediated by the regeneration of crypt stem cells in nursing piglets compared to weaned piglets, is probably responsible for the age-dependent resistance to PED ([@bib0305]). PEDV antigens are mainly observed in villous enterocytes of the small and large intestines. PEDV also infect macrophages infiltrated in the lamina propria *in vivo* ([@bib0430]). Experimental infection of TGEV shows that the lung is the tract sustaining viral replication and IFN synthesis ([@bib0395]). TGEV can replicate in porcine alveolar macrophages (PAMs) *in vitro* and induces a marked synthesis of type I IFNs ([@bib0400]). Similarly, PEDV can also infect and replicate in PAMs *in vivo* ([@bib0555]), suggesting an extra-intestinal replication of PEDV. Additionally, PEDV has been shown to induce apoptotic cell death *in vitro* and *in vivo* through the caspase-independent mitochondrial apoptosis-inducing factor (AIF) pathway ([@bib0350]). Another study claims that PEDV may not induce the death of enterocytes in the small intestine through apoptosis pathway in infected pigs ([@bib0295]).

After binding to APN, PEDV is internalized into target cells by direct membrane fusion, and the genomic RNA is released into the cytosol for replication. The sensing of viral nucleic acids by PRRs in the endosome or cytosol initiates the innate immune signaling. Like other coronaviruses, PEDV likely replicates in the double membrane vesicles to hide the viral RNA from sensing by PRRs and to attenuate the innate immune response ([@bib0025], [@bib0675]). A recent study shows that TLR2, TLR3, and TLR9 may contribute to NF-κB activation in response to PEDV infection in IECs *in vitro* but does not cause RIG-I activation ([@bib0090]). TLR2 on the plasma membrane responds to viral glycoproteins on the envelope to induce production of IFNs and inflammatory cytokines, while TLR3 and TLR9 are localized largely in the endosome to sense dsRNA and CpG DNA, respectively ([@bib0055]). This suggests that PEDV may initiate the innate immune response through its surface glycoprotein and viral nucleic acids in the endosomes. PEDV activates the ERK (extracellular signal-regulated kinase) pathway early during infection independently from viral RNA replication ([@bib0355]). Knockdown or inhibition of ERK suppresses viral transcription, protein expression, and progeny production, which suggest that the activation of ERK pathway is beneficial and required for PEDV replication ([@bib0355]). Proteomics analysis of PEDV-infected cells shows differential expression of proteins involved in apoptosis, signal transduction, and stress responses ([@bib0830]), and ERK1 is significantly downregulated during PEDV infection. Thus, the ERK pathway modulation by PEDV is of further interest to study. In one study, six different signaling pathways have been shown to be differentially regulated by PEDV, which includes the RLR, Rap1, PI3K-Akt, MAPK, JAK-STAT, and TLR signaling pathways ([@bib0710]), suggesting the modulation of host innate immunity by PEDV. For PDCoV, little is known about the viral modulation of host immunity. The PDCoV N protein forms non-covalently linked oligomers localized in the nucleolus ([@bib0425]). The N protein alters the expression of cellular proteins relevant to cell division, metabolism, stress response, protein biosynthesis and transport, cytoskeleton networks, and cell communication ([@bib0425]). Notably, PDCoV N protein upregulates two members of the heat shock protein 70 (HSP70) family. In two lines of swine cells (LLC-PK1 and ST), which are used to isolate and propagate PDCoV ([@bib0320]), apoptosis is induced *in vitro*, but no apoptosis is observed *in vivo* in PDCoV-infected intestinal enterocytes ([@bib0320]). This suggests that a better cell system is needed to mimic *in vivo* conditions for PDCoV infections, and for this purpose IECs, intestinal enteroids, or organoids may be useful ([@bib0190], [@bib0320]).

PEDV infection in suckling pigs does not alter the natural killer (NK) cell activity compared to weaned pigs that show significantly higher NK cell activities in the blood and ileum ([@bib0035]). Interestingly, PEDV infection seems to stimulate a marked induction of serum IFN-α in suckling pigs at 1-day post-infection which then declines to the basal level by 5-day post-infection ([@bib0035]). In weaned pigs however, PEDV infection causes a slight induction of serum IFN-α at 3-day post-infection and a decrease to the basal level at 5-day post-infection. The peak production of serum IFN-α coincides with the peak of viral RNA shedding in the feces and serum of suckling pigs or serum in weaned pigs and the onset of diarrhea. PEDV infection differentially modulates inflammatory cytokines in both suckling and weaned pigs and induces a similar level of TNF-α and IFN-α ([@bib0035]). According to this study, PEDV is capable of modulating IFN-α production especially in weaned pigs. Since PEDV infection occurs in the small intestine as with TGEV, it is of interest to examine IFN-α in the intestinal secretions and how PEDV modulates type I IFN induction in the intestinal pDCs. Intestinal DCs are highly effective antigen-presenting cells distributed beneath the epithelial lining. Unlike TGEV, PEDV infects MoDCs and produces high levels of IL-12 and INF-γ without alteration of the IL-10 expression ([@bib0215]). Interaction between PEDV and MoDCs affects the stimulation of T cell response *in vitro*. PEDV may also enhance the ability of porcine intestinal DCs to sample antigens and activate T-cell proliferation *in vivo* ([@bib0215]). How the intestinal pDCs respond to PEDV infection and modulate innate immune signaling remains to be determined.

4.4. Evasion of IFN response by PEDV {#sec0060}
------------------------------------

IFN-α/β plays an important role in restricting viral infections, and enteric coronaviruses have evolved redundant mechanisms to counteract the host innate immunity for optimal viral adaptation and replication. Even though TGEV activates IFN-α/β production, its accessory protein 7 modulates IFN-α/β expression by interacting with PP1 and prolongs viral dissemination for increased survival ([@bib0135]). Accumulating evidence shows that PEDV also has an ability to evade host IFN response. PEDV does not activate IFN-β expression even after poly(I:C) stimulation in virus-infected cells ([@bib0800], [@bib0835]). It appears that PEDV infection inhibits IRF3 nuclear translocation and thus blocks IRF3-mediated IFN induction. Using MARC-145 cells that are IFN-competent and PEDV-permissive, our laboratory has investigated the innate immune modulatory role of PEDV ([@bib0835]). In our study, the culture supernatants from PEDV-infected cells do not suppress the growth of VSV-GFP, providing evidence for suppression of IFN-α/β by PEDV. Further studies show that PEDV has an ability to degrade the CREB-binding protein (CBP) in the nucleus and thus inhibits the enhanceosome assembly resulting in the suppression of IFN transcription ([@bib0835]). IECs are major target cells of PEDV in pigs, and in these cells, PEDV blocks the activation of MAVS/IPS-1 and IRF3 nuclear translocation in the RIG-I-mediated pathway and do not induce IFN-β expression ([@bib0085]). IPEC-J2 cells are epithelial cells derived from the jejunum of a colostrum-deprived neonatal pig of 12 h of age ([@bib0840]; Dr. A. Blikslager, North Carolina State University). These cells however appear to be non-permissive for PEDV infection (unpublished data), and thus they are less useful than the initial anticipation for the study of PEDV innate immune evasion.

We have individually cloned all coding sequences from PEDV and expressed them to screen for IFN antagonists by luciferase reporter assays. Of 23 viral proteins, 10 proteins are found to suppress IFN induction, which includes both structural proteins and nonstructural proteins: nsp1, nsp3, nsp7, nsp14, nsp15, nsp16, E, M, N, and ORF3 ([@bib0835]). These proteins antagonize the IFN-β and IRF3 activities. Among these, nsp1 is the most potent IFN antagonist, and further studies show that nsp1 does not interfere the IRF3 phosphorylation and nuclear translocation, and rather interrupts the interaction of IRF3 with CREB-binding protein (CBP) and thus inhibits the IFN enhanceosome assembly. PEDV nsp1 triggers CBP degradation in the nucleus in a proteasome-dependent manner, which seems to be the key mechanism for nsp1-mediated IFN suppression ([@bib0835]). PEDV dramatically decreases the level of ubiquitin (Ub)-conjugated proteins in the cytoplasm. Papain-like proteinase 2 (PLP2) in nsp3 of PEDV contains a deubiquitinase (DUB) activity to process the cytosolic K48- and K63-linked polyubiquitin chains ([@bib0800]). PLP2 in nsp3 of both α-CoV and β-CoV could process both lysine-48- and lysine-63- linked polyubiquitin chains of the cytosolic proteins ([@bib0110], [@bib0115], [@bib0125]). SARS-CoV PLP2 reduces the levels of ubiquitinated forms of RIG-I, STING, TRAF3, TBK1, and IRF3 in the STING-TRAF3-TBK1 complex for inhibition of the type I interferon signaling pathway ([@bib0110], [@bib0115]). Similarly, PEDV PLP2 interacts with deubiquitinated RIG-I and STING to antagonize IFN response. PLP2 of SARS-CoV specifically deubiquitinates MDM2 (mouse double minute 2 homolog) and degrades p53 to suppress IFN signaling ([@bib0825]). Similarly, PEDV upregulates MDM2 expression, degrades p53, and significantly inhibits IRF7 expression, suggesting that PEDV PLP2 may also target the p53 pathway for innate immune evasion and inhibit p53-dependent apoptosis ([@bib0825]). Collectively, PEDV differentially modulates ubiquitination level in the cytoplasm and nucleus for modulation of innate immune responses.

PEDV infection leads to activation of the NF-κB pathway in IECs ([@bib0090]). PEDV stimulates nuclear localization of exogenous p65 at 24 h post infection, and increases the nuclear localization of endogenous p65 at 12 h through 48 h post-infection. In another study, PEDV normally induces activation of NF-κB and AP-1 following poly(I:C) stimulation at 24 h post-infection ([@bib0800]). These studies are relatively late stage for PEDV infection. PEDV may inhibit NF-κB activation at an early stage for optimal survival and then activates it at late stage for inflammation. For porcine reproductive and respiratory syndrome virus (PRRSV), which is a porcine arterivirus of the *Nidovirales* order, NF-κB is activated 30 min after infection ([@bib0205]). Thus, how PEDV inhibits NF-κB during an early time of infection is of interest and needs to be explored. For SARS-CoV, the N protein activates NF-κB ([@bib0450]) whereas the M protein suppresses NF-κB, probably through a direct interaction with IKKβ ([@bib0185]). For PEDV, the E and N proteins cause ER stress leading to activation of the NF-κB pathway for up-regulation of IL-8 and Bcl-2 ([@bib0805], [@bib0810]), and the M protein of PEDV is reported to induce a cell cycle arrest at the S phase via the cyclin A pathway ([@bib0815]). In other study, the N protein blocks the IFN-β production and ISGs expression, leading to suppression of the IRF3 and NF-κB activities ([@bib0165]). The N protein is an RNA-binding protein and shuttles between the cytoplasm and nucleus ([@bib0655]). Furthermore, N interacts with TBK1 and sequesters its association with IRF3 to block the phosphorylation and nuclear translocation of IRF3 leading to inhibition of IRF3-mediated IFN production ([@bib0165]). The nsp5 protein of PEDV is a 3C-like proteinase and has been shown as an IFN antagonist. The cysteine proteinase activity of nsp5 cleaves NEMO which is an essential NF-κB modulator and disrupts the RIG-I/MDA5 signaling ([@bib0765]). Modulation of innate immune response and signaling by PEDV infection is summarized in [Table 2](#tbl0010){ref-type="table"} .Table 2Modulation of innate immune response and signaling by PEDV.Table 2Modulation of innate immune responses by PEDVModelReferencesSuppression of IFN-β induction upon poly(I:C) stimulation and inhibits IRF3 nuclear translocation.Vero E6 cells[@bib0800]Suppression of type I IFN induction and degrades CBP in the nucleus.MARC-145 cells[@bib0835]Lack of poly(I:C)-mediated IFN-β induction and blocking activation of IPS-1 in RIG-I-mediated pathway.Intestinal epithelial cells (IECs)[@bib0085]Ativation of NF-κB pathway through TLR2, TLR3, and TLR9.IECs[@bib0090]Activation of extracellular signal-regulated kinase (ERK) pathway early during infection.Vero cells[@bib0355]PEDV infection causes undetectable natural killer (NK) cell activity in suckling piglets compared to weaned pigs.Pigs[@bib0035]A marked induction of serum IFN-α in suckling pigs at 1 day post infection, but it is declined significantly to the base level at 5 days post-infection.Pigs[@bib0035]

For SARS-CoV, nsp14 is an exoribonuclease and nsp15 is an endoribonuclease, and both function through a specific digestion of dsRNA and subsequent removal of RNA-PAMPs, leading to suppression of IFN responses ([@bib0370]). SARS-CoV nsp16 is a 2′-*O*-methlytransferase that modifies the 5′ cap structure of viral RNA and functions to avoid detection by the host immune system ([@bib0735]). PEDV nsp14, nsp15, and nsp16 correspond to nsp14, nsp15, and nsp16 of SARS-CoV and are presumed to share similar functions for innate immune evasion, which needs to be verified experimentally. The M protein plays an important role in viral assembly and induction of PEDV neutralizing antibodies, and a recent study shows that M is an additional IFN antagonist ([@bib0835]). Since M protein of TGEV is responsible for abundant expression of IFN-α, it is of great interest to determine how the PEDV M protein can suppress IFN response and functions differently from the TGEV M protein. ORF3 is the sole accessory protein of PEDV and its role for pathogenesis remains enigmatic. Some strains of cell-adapted PEDV display internal deletions in the ORF3 gene ([@bib0560]), suggesting that ORF3 relates to adaptation and pathogenicity. ORF3 has also been shown to function as an ion channel protein and thus the suppression of ORF3 expression inhibits viral production ([@bib0755]). Additionally, ORF3 delays the S phase in dividing cell and suppresses the cell cycle progression ([@bib0820]). A contradictory data exists that ORF3 causes an inability to recover progeny virus from a full-length infectious clone, suggesting that ORF3 negatively modulates PEDV replication *in vitro* ([@bib0280]). However, the deletion of entire ORF3 by targeted RNA recombination has been possible and ORF3 appears nonessential for PEDV replication *in vitro* ([@bib0445]). ORF3 inhibits type I IFN production ([@bib0835]) and facilitates the vesicle formation in ORF3-expressing cells ([@bib0820]), implicating an important role of ORF3 for innate immune evasion. These viral antagonists may target different signaling pathways to modulate the host innate immunity synergistically and efficiently during infection. The modulation of type I IFN responses by PEDV and the IFN antagonism by PEDV proteins is shown in [Fig. 3](#fig0015){ref-type="fig"}.

4.5. Coronavirus nsp1 as a multifunctional IFN antagonist {#sec0065}
---------------------------------------------------------

Coronavirus nsp1 is the N-terminal cleavage product of polyproteins pp1a and pp1a/b processed by the papain-like proteinase 1 (PLP1) activity of nsp3 ([@bib0850]). The nsp1 gene is one of the most divergent genes among four different genera. Only the genome of α-CoV and β-CoV codes for nsp1, whereas the genome of γ-CoV and δ-CoV lack the nsp1 gene ([@bib0785], [@bib0790], [@bib0850], [@bib0845]). The nsp1 gene of α-CoV is much smaller than that of β-CoV and the sequence homology is also limited. The PEDV nsp1 gene encodes for 110 amino acids with the predicted molecular migration of 12 kD. The protein sequence of nsp1 does not harbor any known cellular functional motifs ([@bib0130]) and thus is a genus-specific genetic marker ([@bib0670]). However, nsp1 of α-CoV and β-CoV share similar functions. Coronavirus nsp1, especially β-CoV nsp1, regulates host cell and viral gene expression ([@bib0520]). The nsp1 protein of α-CoV and β-CoV is a potent IFN antagonist, and among all coronaviruses, SARS-CoV nsp1 is best characterized. SARS-CoV nsp1 inhibits the reporter gene expression under the constitutive promoters as well as the IFN-β promoter ([@bib0325]). As with SARS-CoV nsp1, murine hepatitis coronavirus (MHV) nsp1 and HCoV-229E nsp1 affect the cellular gene expression by suppressing IFN-β, IFN-stimulated response element (ISRE), and SV40 promoter ([@bib0855]). MHV nsp1 facilitates viral replication in mice by suppressing IFN-α/β through an unknown mechanism. MHV nsp1 and SARS-CoV nsp1 are distributed in the cytoplasm of virus-infected cells ([@bib0075], [@bib0325]), and SARS-CoV nsp1 suppresses IFN mRNA accumulation without altering the IRF3 dimerization ([@bib0325]). SARS-CoV nsp1 blocks the NF-κB, IRF3, and IRF7 activities. SARS-CoV nsp1 also inhibits IFN-dependent signaling by interfering STAT1 phosphorylation ([@bib0775]). Bat-CoV nsp1 inhibits type I IFNs and ISGs production ([@bib0730]), HCoV-229E nsp1 and HCoV-NL63 nsp1 also inhibits the IFN-β, ISRE, ISG15 activities as well as the SV40, HSV-TK and CMV promoters ([@bib0750], [@bib0855]). PEDV nsp1 has shown to degrade the CBP in the nucleus to antagonize the type I IFN induction ([@bib0835]; [Fig. 4](#fig0020){ref-type="fig"} A). The p300 protein is a transcriptional co-activator protein for CBP, which functions as histone acetyltransferase and plays a central role in coordinating and integrating multiple signal-dependent events for appropriate level of gene transcription. PEDV nsp1 does not alter the expression level for p300 ([Fig. 4](#fig0020){ref-type="fig"}B), which further confirm the specificity of degradation of CBP. To examine whether the nsp1 protein of other coronaviruses also possessed an activity for type I IFN suppression, nsp1 genes were cloned from TGEV and bovine coronavirus (BCoV) and examined for an IFN suppressive activity using an IFN-β luciferase assay. Similar to PEDV nsp1, TGEV nsp1 and BCoV nsp1 also significantly suppress the IFN-β promoter activities ([Fig. 4](#fig0020){ref-type="fig"}C). TGEV nsp1 has been shown to inhibit host protein synthesis without binding to 40 S ribosomal subunit ([@bib0265]), and BCoV infection activates host innate defense via TLR7/8-dependent pathways and inhibits type I IFNs and pro-inflammatory cytokines ([@bib0005]). It is of interest to investigate the detailed mechanism for TGEV-nsp1- and BCoV-nsp1-mediated IFN suppression.Fig. 4Coronavirus nsp1 is a major IFN antagonist. (A) Degradation of CREB-binding protein (CBP) by PEDV nsp1. Cells were seeded on coverslips and transfected with PEDV nsp1 gene. Porcine reproductive and respiratory syndrome virus (PRRSV) nsp1α is known to degrade CBP in the nucleus and thus included as a control. Cells were stained at 24 h post-transfection for indirect immunofluorescence assay (IFA) using rabbit anti-FLAG polyclonal antibody (red) and mouse anti-CBP monoclonal antibody (green). Nuclei were stained with DAPI (blue). White arrows indicate nsp1-expressing cells. Yellow arrows indicate control cells. (B) PEDV nsp1 does not alter the expression of p300. Cells were grown to 90% confluence and HA-tagged p300 gene was co-transfected with PEDV nsp1 gene or empty vector pXJ41. Cells were stained at 24 h post-transfection for detection of nsp1 (red) using rabbit anti-FLAG polyclonal antibody and for p300 (green) using mouse anti-HA monoclonal antibody. Nuclei were stained with DAPI (blue). (C) Suppression of type I IFN induction by nsp1 of bovine coronavirus (BCoV) and transmissible gastroenteritis coronavirus (TGEV). HeLa cells were seeded in 24-well plates and co-transfected with pIFN-β-luc along with individual nsp1 gene and pRL-TK at a ratio of 1:1:0.1. PRRSV nsp1α is a known IFN suppressor and was included as a control. At 24 h post-transfection, cells were stimulated with poly(I:C) (0.5 μg/ml) for 12 h and the luciferase activities were measured. The reporter experiments were repeated three time, each in triplicate. Asterisks indicate the statistical significance. Statistical analysis was performed by Student's *t*-test. \*, *P *\< 0.05, \*\*, *P *\< 0.01, and \*\*\*, *P *\< 0.001.Fig. 4

5. Conclusion {#sec0070}
=============

Two emerging enteric coronaviruses, PEDV and PDCoV, have caused epidemic and endemic infections in pig populations in many countries and have become a major economic threat to the pork industry. The intestinal epithelial surface is the first line of defense to restrict the enteric viral infections, and both IFN-α/β and IFN-λ are important antiviral cytokines that viruses have evolved to counteract. For PEDV, at least 10 viral IFN-α/β antagonists have been identified in our laboratory. Since enteric coronaviruses infect intestinal epithelial surface, several questions still remain to be answered ([Fig. 2](#fig0010){ref-type="fig"}). Firstly, whether PEDV and PDCoV selectively activate and/or modulate IFN-λ production and whether IFN-λ plays a protective role on the intestinal surface. Secondly, how different cell types such as IECs, pDCs, and IELs in the intestinal barrier induce different types of IFNs and function for mucosal defense. Thirdly, the intestinal epithelium constantly interacts with commensal bacteria and opportunistic viral infections, and thus IFN systems must be able to deal with these organisms without severe inflammation and tissue damages. Thus, better research models for cells and animals are needed to truly reflect viral evasions from innate immune defense. Lastly, specific cytokine mediators are produced in IECs, and how they respond to porcine enteric viral infections is of an additional interest.
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